Refine
Year of publication
- 2014 (365) (remove)
Document Type
- Doctoral Thesis (365) (remove)
Keywords
- Maus (11)
- T-Lymphozyt (10)
- Genexpression (6)
- Thrombozyt (6)
- Transkriptionsfaktor (6)
- Apoptosis (5)
- Ackerschmalwand (4)
- Angiogenese (4)
- Dendritische Zelle (4)
- Epigenetik (4)
Institute
- Graduate School of Life Sciences (62)
- Theodor-Boveri-Institut für Biowissenschaften (49)
- Physikalisches Institut (20)
- Medizinische Fakultät (15)
- Medizinische Klinik und Poliklinik I (15)
- Institut für Informatik (12)
- Fakultät für Chemie und Pharmazie (10)
- Institut für Pharmazie und Lebensmittelchemie (10)
- Institut für Anorganische Chemie (9)
- Institut für Psychologie (9)
Schriftenreihe
Sonstige beteiligte Institutionen
- Universitätsklinikum Münster (2)
- CBIO, University of Cape Town, South Africa (1)
- DLR (1)
- Department of Biochemistry (1)
- Fachhochschule Kaiserslautern, Campus Zweibrücken (1)
- Fraunhofer-Institut für Silicatforschung ISC, Würzburg (1)
- IBMP - Institut für Biomedizinische und Pharmazeutische Forschung in Nürnberg-Heroldsberg (1)
- Institut für Tierökologie und Tropenbiologie (1)
- Institut für klinische Neurobiologie (1)
- Instituto de Hygiene Montevideo, Uruguay (1)
ResearcherID
- I-5818-2014 (1)
Tumor angiogenesis is essential for the growth of solid tumors as their proliferation and survival is dependent on consistent oxygen and nutrient supply. Anti-angiogenic treatments represent a therapeutic strategy to inhibit tumor growth by preventing the formation of new blood vessels leading to starvation of the tumor. One of the best characterized anti angiogenic therapeutics is the monoclonal antibody bevacizumab (Avastin), which targets and neutralizes VEGF leading to disruption of the VEGF signaling pathway. Until today, bevacizumab has found its way into clinical practice and has gained approval for treatment of different types of cancer including colorectal cancer, non-small cell lung cancer, breast cancer and renal cell carcinoma. Signaling of VEGF is mediated through VEGF receptors, mainly VEGFR2, which are primarily located on the cell surface of endothelial cells. However, there has been evidence that expression of VEGF receptors can also be found on tumor cells themselves raising the possibility of autocrine and/or paracrine signaling loops. Thus, tumor cells could also benefit from VEGF signaling, which would promote tumor growth. The aim of this study was to investigate if bevacizumab has a direct effect on tumor cells in vitro. To this end, tumor cell lines from the NCI-60 panel derived from four different tumor types were treated with bevacizumab and angiogenic gene and protein expression as well as biological outputs including proliferation, migration and apoptosis were investigated. Most of the experiments were performed under hypoxia to mimic the in vivo state of tumors. Overall, there was a limited measurable effect of bevacizumab on treated tumor cell lines according to gene and protein expression changes as well as biological functions when compared to endothelial controls. Minor changes in terms of proliferation or gene regulation were evident in a single tumor cell line after VEGF-A blockade by bevacizumab, which partially demonstrated a direct effect on tumor cells. However, the overall analysis revealed that tumor cell lines are not intrinsically affected in an adverse manner by bevacizumab treatment.
Besides the functional analysis of tumor cells, embryonic stem cell derived endothelial cells were characterized to delineate vascular Hey gene functions. Hey and Hes proteins are the best characterized downstream effectors of the evolutionary conserved Notch signaling pathway, which mainly act as transcriptional repressors regulating downstream target genes. Hey proteins play a crucial role in embryonic development as loss of Hey1 and Hey2 in mice in vivo leads to a severe vascular phenotype resulting in early embryonic lethality. The major aim of this part of the thesis was to identify vascular Hey target genes using embryonic stem cell derived endothelial cells utilizing a directed endothelial differentiation approach, as ES cells and their differentiation ability provide a powerful in vitro system to study developmental processes. To this end, Hey deficient and Hey wildtype embryonic stem cells were stably transfected with an antibiotic selection marker driven by an endothelial specific promoter, which allows selection for endothelial cells. ESC-derived endothelial cells exhibited typical endothelial characteristics as shown by marker gene expression, immunofluorescent staining and tube formation ability. In a second step, Hey deficient ES cells were stably transfected with doxycycline inducible Flag-tagged Hey1 and Hey2 transgenes to re-express Hey proteins in the respective cell line. RNA-Sequencing of Hey deficient and Hey overexpressing ES cells as well as ESC-derived endothelial cells revealed many Hey downstream target genes in ES cells and fewer target genes in endothelial cells. Hey1 and Hey2 more or less redundantly regulate target genes in ES cells, but some genes were regulated by Hey2 alone. According to Gene Ontology term analysis, Hey target genes are mainly involved in embryonic development and transcriptional regulation. However, the response of ESC-derived endothelial cells in regulating Hey downstream target genes was rather limited when compared to ES cells, which could be due to lower transgene expression in endothelial cells. The limited response also raises the possibility that target gene regulation in endothelial cells is not only dependent on Hey gene functions alone and thus loss or overexpression of Hey genes in this in vitro setting does not influence target gene regulation.
Today’s Internet architecture was not designed from scratch but was driven by new services that emerged during its development. Hence, it is often described as patchwork where additional patches are applied in case new services require modifications to the existing architecture. This process however is rather slow and hinders the development of innovative network services with certain architecture or network requirements. Currently discussed technologies like Software-Defined Networking (SDN) or Network Virtualization (NV) are seen as key enabling technologies to overcome this rigid best effort legacy of the Internet. Both technologies offer the possibility to create virtual networks that accommodate the specific needs of certain services. These logical networks are operated on top of a physical substrate and facilitate flexible network resource allocation as physical resources can be added and removed depending on the current network and load situation. In addition, the clear separation and isolation of networks foster the development of application-aware networks that fulfill the special requirements of emerging applications. A prominent use case that benefits from these extended capabilities of the network is denoted with service component mobility. Services hosted on Virtual Machines (VMs) follow their consuming mobile endpoints, so that access latency as well as consumed network resources are reduced. Especially for applications like video streaming, which consume a large fraction of the available resources, is this an important means to relieve the resource constraints and eventually provide better service quality. Service and endpoint mobility both allow an adaptation of the used paths between an offered service, i.e., video streaming and the consuming users in case the service quality drops due to network problems. To make evidence-based adaptations in case of quality drops, a scalable monitoring component is required that is able to monitor the service quality for video streaming applications with reliable accuracy. This monograph details challenges that arise when deploying a certain service, i.e., video streaming, in a future virtualized network architecture and discusses possible solutions. In particular, this work evaluates the performance of mechanisms enabling service mobility and presents an optimized architecture for service mobility. Concerning endpoint mobility, improvements are developed that reduce the latency between endpoints and consumed services and ensure connectivity regardless of the used mobile access network. In the last part, a network-based video quality monitoring solution is developed and its accuracy is evaluated.
Die erfolgreiche therapeutische Beeinflussung pathophysiologischer Prozesse im Herzen nach myokardialem Infarkt stellt nicht zuletzt durch die steigenden Fallzahlen in der westlichen Welt und die vergleichsweise hohe Mortalität eine Herausforderung an Forschung und Entwicklung dar. In der vorliegenden Arbeit werden verschiedene therapeutische Strategien in klinisch relevanten Mausmodellen des Myokardinfarkts und des Ischämie-Reperfusions-Schadens getestet.
Zunächst wird untersucht, ob sich der Einsatz des NFκB-aktivierenden Zytokins TWEAK, welches weitreichende Funktionen in physiologischen Prozessen wie Wundheilung und Entzündung besitzt, als eine mögliche Therapiestrategie eignet. Die Expression von TWEAK wird nach myokardialem Infarkt stark im Herzgewebe induziert. Das gleiche gilt für den Rezeptor von TWEAK, Fn14, der vor allem auf kardialen Fibroblasten exprimiert wird. Daher wird angenommen, dass das TWEAK-Fn14-System am kardialen Remodelling und der Wundheilung im infarzierten Herzen beteiligt sein kann.
Eine rekombinante Variante von TWEAK - HSA-Flag-TWEAK - wird im Mausmodell des Myokardinfarkts getestet. Überraschenderweise zeigt sich hierbei, dass die therapeutische Behandlung von infarzierten Versuchstieren mit diesem Protein die Mortalität im Vergleich zu Placebo-behandelten Mäusen signifikant erhöht. Dies geht mit einem vermehrten Auftreten an linksventrikulären Rupturen einher, ohne dass Defekte im kardialen Remodelling oder eine erhöhte Apoptoserate im Herzen festgestellt werden können. HSA-Flag-TWEAK bewirkt eine Erhöhung der Gewebekonzentrationen an verschiedenen pro-inflammatorischen Zytokinen (IFN-γ, IL-5, IL-12, GITR, MCP-1/-5 und RANTES) und das vermehrte Einwandern von Immunzellen in das Myokard. Hierbei ist insbesondere die stark erhöhte Infiltration an neutrophilen Granulozyten auffällig. Ein kausaler Zusammenhang zwischen diesen Immunzellen und den auftretenden kardialen Rupturen kann durch die Depletion der Neutrophilen gezeigt werden: Nach der systemischen Applikation eines Ly6G-depletierenden Antikörpers ist das Auftreten von kardialen Rupturen nach TWEAK-Gabe vergleichbar mit der Placebo-behandelten Infarktgruppe. Die Tatsache, dass die Mortalität dennoch erhöht ist, deutet auf weitere negative Effekte durch TWEAK hin. Diese Ergebnisse legen die Vermutung nahe, dass eine Hemmung der TWEAK-Fn14-Achse positive Effekte auf die Wundheilung nach Herzinfarkt bewirken könnte.
Als zweite Therapiestrategie wird die pharmakologische Beeinflussung verschiedener Blutplättchen-spezifischer Zielstrukturen untersucht, um das Auftreten von Mikrothromben nach Myokardinfarkt zu reduzieren. Eine Hemmung über das Blutplättchen-Glykoprotein GPVI bewirkt in dem hier eingesetzten Mausmodell der kardialen Ischämie-Reperfusion eine signifikant verbesserte Mikrozirkulation sowie verringerte Infarktgrößen. GPVI stellt somit ein vielversprechendes Ziel für eine blutplättchenhemmende Therapie nach Myokardinfarkt dar.
Zusammengefasst werden in der vorliegenden Arbeit verschiedene neuartige Therapieoptionen untersucht, die die Auswirkungen ischämischer Erkrankungen des Herzens beeinflussen können. Die Ergebnisse besitzen daher das Potenzial, zur Entwicklung neuer Therapien nach Myokardinfarkt beizutragen.
The discontinuous mountain permafrost zone is characterized by its heterogeneous distribution of frozen ground and a small-scale variability of the ground thermal regime. Large parts of these areas are covered by glacial till and sediments that were exposed after the recession of the glaciers since the 19th century. As response to changed climatic conditions permafrost-affected areas will lose their ability as sediment storage and on the contrary, they will act as source areas for unconsolidated debris. Along with modified precipitation patterns the degradation of the discontinuous mountain permafrost zone will (temporarily)
increase its predisposition for mass movement processes and thus has to be monitored in a differentiated way.
Therefore, the spatio-temporal dynamics of frozen ground are assessed in this study based on results obtained in three glacier forefields in the Engadin (Swiss Alps) and at the Zugspitze (German Alps). Sophisticated techniques are required to uncover structural differences in the subsurface. Thus, the applicability of advanced geophysical methods is tested for alpine environments and proved by the good 3D-delineation of a permafrost body and by the detection of detailed processes in the active layer during snow melt. Electrical resistivity tomography (ERT) approaches (quasi-3D, daily monitoring) reveal
their capabilities to detect subsurface resistivity changes both, in space and time. Processes and changes in regard to liquid water content and ice content are observed to exist at short distances even though the active layer is not subject to a considerable thickening
over the past 7 years. The stability of the active layer is verified by borehole temperature data. No synchronous
trend is recognized in permafrost temperatures and together with multi-annual electrical resistivity data they indicate degradation and aggradation processes to occur at the same time. Different heat transfer mechanisms, especially during winter, are recognized by means of temperature sensors above, at, and beneath the surface. Based on surface and borehole temperature data the snow cover is assessed as the major controlling factor for the thermal regime on a local scale. Beyond that, the debris size of the substrate, which modifies the snow cover and regulates air exchange processes above the ground, plays a crucial role as an additional buffer layer. A fundamental control over the stability of local permafrost patches is attributed to the ice-rich transient layer at the base of the active layer. The refreezing of melt water in spring is illustrated with diurnal ERT monitoring data from glacier forefield Murtèl.
Based on these ERT and borehole temperature data a conceptual model of active layer processes between autumn and spring is developed. The latent heat that is inherent in the transient layer protects the permafrost beneath from additional energy input from the surface as long as the refreezing of melt water in spring prevails and sufficient ice is build up each spring. Permafrost sites without a transient layer show considerably higher
temperatures at their table and are more prone to degradation in the years and decades ahead. As main investigation area a glacier forefield beneath the summits of Piz Murtèl and Piz Corvatsch in the Swiss Engadin was chosen. It is located west of the well-known
rock glacier Murtèl. Here, a permafrost body inside and adjacent to the lateral moraine was investigated and could be delineated very well. In the surrounding glacier forefield no further indications of permafrost occurrence could be made. Geophysical data and temperature values from the surface and from a permafrost borehole were compared with long-term data from proximate glacier forefield Muragl (Engadin). Results from both
sites show a considerable stability of the active layer depth in summer while at the same time geophysical data demonstrate annual changes in the amount of liquid water content and ice content in the course of years.
A third investigation area is located in the German Alps. The Zugspitzplatt is a high mountain valley with considerably more precipitation and thicker snow cover compared to both Swiss sites. In close proximity to the present glacier and at a large talus slope beneath the summit crest ground ice could be observed. The high subsurface resistivity values and comparable data from existing studies at the Zugspitze may indicate the presence of sedimentary ice in the subsurface of the karstified Zugspitzplatt. Based on these complementary data from geophysical and temperature measurements as
well as geomorphological field mapping the development of permafrost in glacier forefields under climate change conditions is analyzed with cooperation partners from the SPCC project. Ground temperature simulations forced with long-term climatological data are modeled to assess future permafrost development in glacier forefield Murtèl. Results suggest that permafrost is stable as long as the ice-rich layer between the active layer and
the permafrost table exists. After a tipping point is reached, the disintegration of frozen ground starts to proceed rapidly from the top.
Trotz deutlich zunehmender Durchimpfungsraten bei Kindern und Jugendlichen tritt Pertussis in Deutschland weiterhin als Ursache signifikanter Morbidität auf, v. a. bei ungeimpften Kindern und Säuglingen. Die Datenlage zur Pertussis-Epidemiologie ist vor allem in den alten Bundesländern aufgrund der bis 2013 fehlenden Meldepflicht sehr begrenzt. Das Ziel dieser Studie war die Ermittlung der Inzidenz und des Schweregrades von ICD-10-dokumentierten Bordetella pertussis-Hospitalisationen bei Kindern in Bayern.
27 (73%) von insgesamt 37 bayerischen Kinderkliniken beteiligten sich an der Surveillance-Studie. Sie führten eine Datenabfrage für im Jahr 2007 und 2008 stationär aufgenommene Kinder unter 17 Jahren mit einem ICD- 10-Code für Pertussis (A37.0 oder A37.9) als Haupt- oder Nebendiagnose bei Entlassung durch. Zu diesen Kindern wurden demographische Basisdaten sowie Jahr und Monat der Hospitalisation, Haupt- und alle Nebendiagnosen, Aufenthaltsdauer und Behandlung (OPS-Codes) erhoben.
Im 2-Jahres-Zeitraum 2007/2008 wurden insgesamt 171 Fälle identifiziert (2007:109 Fälle; 2008: 62 Fälle), mit 0-17 gemeldeten Fällen pro Klinik. Mädchen waren mit 51% (n=88) etwas häufiger betroffen als Jungen. Der Altersmedian lag bei vier Monaten (IQR: 1-14 Monate); 121 (70.7%) Kinder waren Säuglinge <1 Jahr, 102 (59.6%) <6 Monate und 41 (24.0%) <2 Monate alt. Die jährliche Inzidenz bei Säuglingen <1 Jahr wurde auf 67/100.000 Hospitalisationen geschätzt, bei Säuglingen <2 Monate auf 22/100.000. Respiratorische Komplikationen einschließlich Pneumonien und Apnoen traten bei 31% (n=53) aller Kinder auf; von diesen waren 82% (n=39) <1 Jahr bzw. 44% (n=21) <2 Monate alt. Fünf Kinder (3%) mussten intensivstationär behandelt werden, davon waren 4 jünger als 4 Monate. Bei einem Säugling (0.6%) war ein Krampfanfall dokumentiert, kardio-respiratorische Komplikationen kamen bei 2% und Dehydratation bei 8% aller Kinder vor.
Sowohl die Inzidenz der Hospitalisationen als auch die Komplikationsrate waren am höchsten bei Säuglingen <1 Jahr bzw. <2 Monaten. Die Ergebnisse belegen die Bedeutung der zeitgerechten Umsetzung der Impfempfehlung, d.h. den rechtzeitigen Start der Grundimmunisierung im Alter von 2, 3 und 4 Monaten. Auch die bereits 2004 empfohlene Impfung von Kontaktpersonen ist für die Prävention von Pertussis bei Säuglingen von hoher Wichtigkeit. Die bisher nicht allgemein empfohlene Impfung für Schwangere bzw. für Neugeborene könnte ggf. die Hospitalisationszahlen weiter senken; weitere Studien dazu werden dringend benötigt.